Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging.

Knopman DS, Beiser A, Machulda MM, Fields J, Roberts RO, Pankratz VS, Aakre J, Cha RH, Rocca WA, Mielke MM, Boeve BF, Devine S, Ivnik RJ, Au R, Auerbach S, Wolf PA, Seshadri S, Petersen RC.

Neurology. 2015 Nov 10;85(19):1712-21. doi: 10.1212/WNL.0000000000002100. Epub 2015 Oct 9. Review.

2.

TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.

Josephs KA, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Liesinger AM, Petrucelli L, Senjem ML, Ivnik RJ, Parisi JE, Petersen RC, Dickson DW.

Ann Neurol. 2015 Nov;78(5):697-709. doi: 10.1002/ana.24493. Epub 2015 Sep 16.

3.

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.

Carrasquillo MM, Crook JE, Pedraza O, Thomas CS, Pankratz VS, Allen M, Nguyen T, Malphrus KG, Ma L, Bisceglio GD, Roberts RO, Lucas JA, Smith GE, Ivnik RJ, Machulda MM, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2015 Jan;36(1):60-7. doi: 10.1016/j.neurobiolaging.2014.07.042. Epub 2014 Aug 4.

4.

Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging.

Knopman DS, Roberts RO, Pankratz VS, Cha RH, Rocca WA, Mielke MM, Boeve BF, Tangalos EG, Ivnik RJ, Geda YE, Petersen RC.

Am J Epidemiol. 2014 Aug 15;180(4):414-23. doi: 10.1093/aje/kwu103. Epub 2014 May 23.

5.

TDP-43 is a key player in the clinical features associated with Alzheimer's disease.

Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, Petrucelli L, Senjem ML, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Jack CR Jr, Parisi JE, Petersen RC, Dickson DW.

Acta Neuropathol. 2014;127(6):811-24. doi: 10.1007/s00401-014-1269-z. Epub 2014 Mar 23.

6.

Association of type 2 diabetes with brain atrophy and cognitive impairment.

Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, Senjem ML, Pankratz VS, Geda YE, Boeve BF, Ivnik RJ, Rocca WA, Petersen RC, Jack CR Jr.

Neurology. 2014 Apr 1;82(13):1132-41. doi: 10.1212/WNL.0000000000000269. Epub 2014 Mar 19.

7.

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.

Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, Geda YE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA, Petersen RC.

Neurology. 2014 Jan 28;82(4):317-25. doi: 10.1212/WNL.0000000000000055. Epub 2013 Dec 18.

8.

Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.

Machulda MM, Pankratz VS, Christianson TJ, Ivnik RJ, Mielke MM, Roberts RO, Knopman DS, Boeve BF, Petersen RC.

Clin Neuropsychol. 2013;27(8):1247-64. doi: 10.1080/13854046.2013.836567. Epub 2013 Sep 17.

9.

MRI and MRS predictors of mild cognitive impairment in a population-based sample.

Kantarci K, Weigand SD, Przybelski SA, Preboske GM, Pankratz VS, Vemuri P, Senjem ML, Murphy MC, Gunter JL, Machulda MM, Ivnik RJ, Roberts RO, Boeve BF, Rocca WA, Knopman DS, Petersen RC, Jack CR Jr.

Neurology. 2013 Jul 9;81(2):126-33. doi: 10.1212/WNL.0b013e31829a3329. Epub 2013 Jun 12.

10.

Mild cognitive impairment due to Alzheimer disease in the community.

Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR Jr.

Ann Neurol. 2013 Aug;74(2):199-208. doi: 10.1002/ana.23931.

11.

Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.

Pedraza O, Allen M, Jennette K, Carrasquillo M, Crook J, Serie D, Pankratz VS, Palusak R, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts RO, Lucas JA, Ivnik RJ, Smith GE, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Alzheimers Dement. 2014 Mar;10(2):205-13. doi: 10.1016/j.jalz.2013.01.016. Epub 2013 May 2.

12.

Association of diabetes with amnestic and nonamnestic mild cognitive impairment.

Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Baertlein L, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM, Petersen RC.

Alzheimers Dement. 2014 Jan;10(1):18-26. doi: 10.1016/j.jalz.2013.01.001. Epub 2013 Apr 3.

13.

Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women.

Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM, Petersen RC.

JAMA Neurol. 2013 Mar 1;70(3):374-82. doi: 10.1001/jamaneurol.2013.607.

14.

Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging.

Mielke MM, Roberts RO, Savica R, Cha R, Drubach DI, Christianson T, Pankratz VS, Geda YE, Machulda MM, Ivnik RJ, Knopman DS, Boeve BF, Rocca WA, Petersen RC.

J Gerontol A Biol Sci Med Sci. 2013 Aug;68(8):929-37. doi: 10.1093/gerona/gls256. Epub 2012 Dec 18.

15.

Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion.

Coon EA, Daube JR, Dejesus-Hernandez M, Adeli A, Savica R, Parisi JE, Dickson DW, Josephs KA, Baker MC, Johnson KA, Ivnik RJ, Petersen RC, Knopman DS, Boylan KB, Rademakers R, Boeve BF.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Mar;14(2):132-7. doi: 10.3109/17482968.2012.724075. Epub 2012 Oct 4.

PMID:
23035801
16.

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Boeve BF, Petersen RC.

Neurology. 2012 May 15;78(20):1576-82. doi: 10.1212/WNL.0b013e3182563bbe. Epub 2012 May 2. Erratum in: Neurology. 2017 Aug 29;89(9):980.

17.

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.

Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Rocca WA, Boeve BF, Petersen RC.

Ann Neurol. 2012 Jun;71(6):765-75. doi: 10.1002/ana.22628. Epub 2012 Apr 9.

18.

The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging.

Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Rocca WA, Petersen RC.

Neurology. 2012 Jan 31;78(5):342-51. doi: 10.1212/WNL.0b013e3182452862. Epub 2012 Jan 25.

19.

Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study.

Boot BP, Boeve BF, Roberts RO, Ferman TJ, Geda YE, Pankratz VS, Ivnik RJ, Smith GE, McDade E, Christianson TJ, Knopman DS, Tangalos EG, Silber MH, Petersen RC.

Ann Neurol. 2012 Jan;71(1):49-56. doi: 10.1002/ana.22655.

20.

Reliable change on the Boston naming test.

Sachs BC, Lucas JA, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR, Pedraza O.

J Int Neuropsychol Soc. 2012 Mar;18(2):375-8. doi: 10.1017/S1355617711001810. Epub 2012 Jan 23.

21.

APOE modifies the association between Aβ load and cognition in cognitively normal older adults.

Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Neurology. 2012 Jan 24;78(4):232-40. doi: 10.1212/WNL.0b013e31824365ab. Epub 2011 Dec 21.

22.

Diagnostic validity of age and education corrections for the Mini-Mental State Examination in older African Americans.

Pedraza O, Clark JH, O'Bryant SE, Smith GE, Ivnik RJ, Graff-Radford NR, Willis FB, Petersen RC, Lucas JA.

J Am Geriatr Soc. 2012 Feb;60(2):328-31. doi: 10.1111/j.1532-5415.2011.03766.x. Epub 2011 Dec 8.

23.

Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.

Kantarci K, Lowe V, Przybelski SA, Senjem ML, Weigand SD, Ivnik RJ, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Neurology. 2011 Sep 6;77(10):951-8. doi: 10.1212/WNL.0b013e31822dc7e1. Epub 2011 Aug 24.

24.

Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study.

Geda YE, Topazian HM, Roberts LA, Roberts RO, Knopman DS, Pankratz VS, Christianson TJ, Boeve BF, Tangalos EG, Ivnik RJ, Petersen RC.

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):149-54. doi: 10.1176/appi.neuropsych.23.2.149. Erratum in: J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):500. Lewis, Robert A [corrected to Roberts, Lewis A].

25.

Successful aging: definitions and prediction of longevity and conversion to mild cognitive impairment.

Negash S, Smith GE, Pankratz S, Aakre J, Geda YE, Roberts RO, Knopman DS, Boeve BF, Ivnik RJ, Petersen RC.

Am J Geriatr Psychiatry. 2011 Jun;19(6):581-8. doi: 10.1097/JGP.0b013e3181f17ec9.

26.

Diffusion tensor imaging and cognitive function in older adults with no dementia.

Kantarci K, Senjem ML, Avula R, Zhang B, Samikoglu AR, Weigand SD, Przybelski SA, Edmonson HA, Vemuri P, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Petersen RC, Jack CR Jr.

Neurology. 2011 Jul 5;77(1):26-34. doi: 10.1212/WNL.0b013e31822313dc. Epub 2011 May 18.

27.

What is the quality of life in the oldest old?

Lapid MI, Rummans TA, Boeve BF, McCormick JK, Pankratz VS, Cha RH, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC.

Int Psychogeriatr. 2011 Aug;23(6):1003-10. doi: 10.1017/S1041610210002462. Epub 2011 Feb 1.

28.

Predicting functional decline in behavioural variant frontotemporal dementia.

Josephs KA Jr, Whitwell JL, Weigand SD, Senjem ML, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Jack CR Jr, Petersen RC.

Brain. 2011 Feb;134(Pt 2):432-48. doi: 10.1093/brain/awq348. Epub 2011 Jan 20.

29.

Association of common KIBRA variants with episodic memory and AD risk.

Burgess JD, Pedraza O, Graff-Radford NR, Hirpa M, Zou F, Miles R, Nguyen T, Li M, Lucas JA, Ivnik RJ, Crook J, Pankratz VS, Dickson DW, Petersen RC, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2011 Mar;32(3):557.e1-9. doi: 10.1016/j.neurobiolaging.2010.11.004. Epub 2010 Dec 24.

30.

Utility of the DRS for predicting problems in day-to-day functioning.

Fields JA, Machulda M, Aakre J, Ivnik RJ, Boeve BF, Knopman DS, Petersen RC, Smith GE.

Clin Neuropsychol. 2010 Oct;24(7):1167-80. doi: 10.1080/13854046.2010.514865.

PMID:
20924981
31.

Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging.

Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Rocca WA.

Neurology. 2010 Sep 7;75(10):889-97. doi: 10.1212/WNL.0b013e3181f11d85.

32.

Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging.

Roberts RO, Cerhan JR, Geda YE, Knopman DS, Cha RH, Christianson TJ, Pankratz VS, Ivnik RJ, O'Connor HM, Petersen RC.

J Alzheimers Dis. 2010;21(3):853-65. doi: 10.3233/JAD-2010-091597.

33.

Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment.

Roberts RO, Geda YE, Cerhan JR, Knopman DS, Cha RH, Christianson TJ, Pankratz VS, Ivnik RJ, Boeve BF, O'Connor HM, Petersen RC.

Dement Geriatr Cogn Disord. 2010;29(5):413-23. doi: 10.1159/000305099. Epub 2010 May 22.

34.

Robust and expanded norms for the Dementia Rating Scale.

Pedraza O, Lucas JA, Smith GE, Petersen RC, Graff-Radford NR, Ivnik RJ.

Arch Clin Neuropsychol. 2010 Aug;25(5):347-58. doi: 10.1093/arclin/acq030. Epub 2010 Apr 28.

35.

Physical exercise, aging, and mild cognitive impairment: a population-based study.

Geda YE, Roberts RO, Knopman DS, Christianson TJ, Pankratz VS, Ivnik RJ, Boeve BF, Tangalos EG, Petersen RC, Rocca WA.

Arch Neurol. 2010 Jan;67(1):80-6. doi: 10.1001/archneurol.2009.297.

36.

Mild cognitive impairment: ten years later.

Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr.

Arch Neurol. 2009 Dec;66(12):1447-55. doi: 10.1001/archneurol.2009.266. Review.

37.

Two distinct subtypes of right temporal variant frontotemporal dementia.

Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, Senjem ML, Parisi JE, Ivnik RJ, Dickson DW, Petersen RC, Jack CR Jr.

Neurology. 2009 Nov 3;73(18):1443-50. doi: 10.1212/WNL.0b013e3181bf9945.

38.

Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations.

Whitwell JL, Jack CR Jr, Boeve BF, Senjem ML, Baker M, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Rademakers R, Josephs KA.

Neurology. 2009 Sep 29;73(13):1058-65. doi: 10.1212/WNL.0b013e3181b9c8b9.

39.

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study.

Whitwell JL, Przybelski SA, Weigand SD, Ivnik RJ, Vemuri P, Gunter JL, Senjem ML, Shiung MM, Boeve BF, Knopman DS, Parisi JE, Dickson DW, Petersen RC, Jack CR Jr, Josephs KA.

Brain. 2009 Nov;132(Pt 11):2932-46. doi: 10.1093/brain/awp232. Epub 2009 Sep 17.

40.

Association of C-reactive protein with mild cognitive impairment.

Roberts RO, Geda YE, Knopman DS, Boeve BF, Christianson TJ, Pankratz VS, Kullo IJ, Tangalos EG, Ivnik RJ, Petersen RC.

Alzheimers Dement. 2009 Sep;5(5):398-405. doi: 10.1016/j.jalz.2009.01.025.

41.

Differential item functioning of the Boston Naming Test in cognitively normal African American and Caucasian older adults.

Pedraza O, Graff-Radford NR, Smith GE, Ivnik RJ, Willis FB, Petersen RC, Lucas JA.

J Int Neuropsychol Soc. 2009 Sep;15(5):758-68. doi: 10.1017/S1355617709990361. Epub 2009 Jul 2.

42.

Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study.

Roberts RO, Geda YE, Knopman DS, Cha RH, Boeve BF, Ivnik RJ, Pankratz VS, Tangalos EG, Petersen RC.

Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):11-8. doi: 10.1097/WAD.0b013e3181a4485c.

43.

Association of prior stroke with cognitive function and cognitive impairment: a population-based study.

Knopman DS, Roberts RO, Geda YE, Boeve BF, Pankratz VS, Cha RH, Tangalos EG, Ivnik RJ, Petersen RC.

Arch Neurol. 2009 May;66(5):614-9. doi: 10.1001/archneurol.2009.30.

44.

Functional magnetic resonance imaging changes in amnestic and nonamnestic mild cognitive impairment during encoding and recognition tasks.

Machulda MM, Senjem ML, Weigand SD, Smith GE, Ivnik RJ, Boeve BF, Knopman DS, Petersen RC, Jack CR.

J Int Neuropsychol Soc. 2009 May;15(3):372-82. doi: 10.1017/S1355617709090523.

45.

Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN.

Whitwell JL, Jack CR Jr, Boeve BF, Senjem ML, Baker M, Rademakers R, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Josephs KA.

Neurology. 2009 Mar 3;72(9):813-20. doi: 10.1212/01.wnl.0000343851.46573.67.

46.

The influence of apolipoprotein E genotype on visuospatial attention dissipates after age 80.

Negash S, Greenwood PM, Sunderland T, Parasuraman R, Geda YE, Knopman DS, Boeve BF, Ivnik RJ, Petersen RC, Smith GE.

Neuropsychology. 2009 Jan;23(1):81-9. doi: 10.1037/a0014014.

47.

Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.

Kantarci K, Petersen RC, Przybelski SA, Weigand SD, Shiung MM, Whitwell JL, Negash S, Ivnik RJ, Boeve BF, Knopman DS, Smith GE, Jack CR Jr.

Arch Neurol. 2008 Dec;65(12):1621-8. doi: 10.1001/archneur.65.12.1621.

48.

The anatomic correlate of prosopagnosia in semantic dementia.

Josephs KA, Whitwell JL, Vemuri P, Senjem ML, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Petersen RC, Jack CR Jr.

Neurology. 2008 Nov 11;71(20):1628-33. doi: 10.1212/01.wnl.0000334756.18558.92.

49.

Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.

Geda YE, Roberts RO, Knopman DS, Petersen RC, Christianson TJ, Pankratz VS, Smith GE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA.

Arch Gen Psychiatry. 2008 Oct;65(10):1193-8. doi: 10.1001/archpsyc.65.10.1193.

50.

Detecting dementia with the mini-mental state examination in highly educated individuals.

O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA.

Arch Neurol. 2008 Jul;65(7):963-7. doi: 10.1001/archneur.65.7.963.

Supplemental Content

Support Center